Company / FCF Margin
Adaptive Biotechnologies Corp FCF Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-17.7%
FY2025
5-year range
-164.9% / -17.7%
FY2021-FY2025
Trend
+68.0%
vs FY2024
Sector context
#72 of 133
Health Care
What the data says
At -17.7%, Adaptive Biotechnologies Corp's fcf margin ranks #72 of 133 in the Health Care sector. FCF Margin has increased for 5 consecutive years, from -171.3% in FY2020 to -17.7% in FY2025.
Based on SEC 10-K filings.
-17.7% in FY2025 with a 5-year CAGR of +153.6%.
Improved from -98.1% to -17.7% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +90.4pp
- 5-Year Change
- +153.6pp
- 10-Year Change
- -
Sector benchmark
#72 of 133 in Health CareTop 54% of 133This company -17.7% Sector average -632.8%
▼
+97.2% above sector average
Key checks
Key Insights
- Adaptive Biotechnologies Corp's fcf margin has grown for 5 consecutive years.
- In FY2025, fcf margin increased 68.0% year-over-year.
- Currently 615.2pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -17.7% | +68.0% |
| FY2024 | -55.3% | +43.7% |
| FY2023 | -98.1% | +9.3% |
| FY2022 | -108.1% | +34.4% |
| FY2021 | -164.9% | +3.7% |
| FY2020 | -171.3% | -175.0% |
| FY2019 | 228.3% | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026